Recombinant Human IDO Protein，His

IDO (indoleamine 2,3-dioxygenase) is an enzyme that plays a crucial role in the metabolism of tryptophan, an essential amino acid, by catalyzing its conversion into kynurenine. This metabolic pathway is integral to various physiological processes, particularly in the regulation of immune responses and in the maintenance of immune tolerance. In recent years, research has highlighted the significance of IDO in cancer biology, autoimmune diseases, and transplantation. Tumor cells often exploit IDO to suppress the immune system, thereby evading detection and destruction by immune cells. Furthermore, elevated IDO activity has been associated with chronic inflammation and neurodegenerative disorders. As a result, IDO has garnered attention as a potential therapeutic target, with efforts directed towards developing IDO inhibitors to enhance anti-tumor immunity or modulate immune responses in other pathological conditions. Recombination techniques have been employed to produce IDO as a recombinant protein, facilitating the study of its structure-function relationships, enzyme kinetics, and the development of IDO-based therapeutic interventions. Understanding the molecular mechanisms underlying IDO's activity and its effects on various biological systems could provide insights into new therapeutic strategies for treating a wide array of diseases. Researchers are keen to explore how manipulating IDO pathways can alter disease outcomes, paving the way for innovative treatments that leverage the enzyme's function in immune modulation and metabolic regulation.